ISR Immune System Regulation Holding AB (publ) (ISR.ST)
Stock analysis · STO · Healthcare · Biotechnology
Market Cap
N/A
PE (TTM)
N/A
EPS (TTM)
N/A
Dividend Yield
N/A
Beta
0.44
Day Range
N/A
52-wk Range
N/A
Avg Volume
N/A
Volume
N/A
ISR Immune System Regulation Holding AB (publ) (ISR.ST) is a publicly traded company in the Healthcare sector. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.
Get full analysis → Short-Term Analysis →Proprietary Signals
About ISR Immune System Regulation Holding AB (publ)
ISR Immune System Regulation Holding AB (publ), headquartered in Stockholm, Sweden, is dedicated to the discovery and development of pharmaceutical solutions for viral infections. Its current therapeutic pipeline features a Covid-19 vaccine candidate, treatments for Hepatitis B (HBV) and HIV, and an oncology program.
Peers
Recent News
- No recent news available.
Related
Browse more tickers: sitemap